Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer, Novartis, Merck, and Intravacc are competing in the high-cost gene therapy market, utilizing specialized manufacturing and vaccine production services.Sub-event
- Pfizer and Novartis are notable market players in epilepsy therapeutics.Sub-event
- Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.Sub-event
- Cytokinetics and Pfizer announced strong US sales growth for Camzyos and a co-development agreement for Eliquis.Sub-event
Market growth in advanced therapies driven by Pfizer, Novartis, and Merck.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Novartis
Swiss-American multinational pharmaceutical corporation
-
Merck
public company in Indonesia
Related events
- Merck's stock price increased following positive drug performance involving Summit Therapeutics.
- Healthcare stocks surged to record highs on August 19, 2026, amid market excitement over drug breakthroughs involving Moderna, Amgen, and Merck.
- Pfizer, Johnson & Johnson, and Merck are facing significant industry pressures due to patent cliffs and market pricing demands.
- FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.
- Major pharmaceutical companies are part of the ten largest global pharma giants as the industry seeks to weaken drug price negotiation.
Coverage
Newest first; wire copies grouped- GlobeNewswireChronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma Th